E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases

E10A, a replication-defective adenovirus carrying human endostatin gene, has finished Phase I clinical trials for solid cancers. We assessed whether the combination of E10A with docetaxel would enhance antiangiogenic activities and inhibit prostate cancer growth and metastases. Combination use of co...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zhao, Peng, Luo, Rongcheng, Wu, Jiangxue, Xie, Fajun, Li, Hongli, Xiao, Xia, Fu, Liwu, Zhu, Xiaofeng, Liu, Ranyi, Zhu, Yinghui, Liang, Zhihui, Huang, Wenlin
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2010
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837610/
https://ncbi.nlm.nih.gov/pubmed/26065034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1582-4934.2008.00548.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items